Open | - |
Close | - |
Volume / Avg. | 101.000 / 27.985K |
Day Range | - - - |
52 Wk Range | 2.190 - 16.740 |
Market Cap | $4.191M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 0.36% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Finch Therapeutics Gr (NASDAQ: FNCH) through any online brokerage.
Other companies in Finch Therapeutics Gr’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Geovax Labs (NASDAQ:GOVX) and Genprex (NASDAQ:GNPX).
The latest price target for Finch Therapeutics Gr (NASDAQ: FNCH) was reported by HC Wainwright & Co. on Friday, May 12, 2023. The analyst firm set a price target for 7.00 expecting FNCH to rise to within 12 months (a possible 168.20% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Finch Therapeutics Gr (NASDAQ: FNCH) is $2.61 last updated Today at March 19, 2024 at 9:18 AM EDT.
There are no upcoming dividends for Finch Therapeutics Gr.
Finch Therapeutics Gr’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Finch Therapeutics Gr.
Finch Therapeutics Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.